Clinical Chemistry

Article	Citations
Rapid Detection of COVID-19 Coronavirus Using a Reverse Transcriptional Loop-Mediated Isothermal Amplification (RT-LAMP) Diagnostic Platform	311
The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020	250
Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads	183
Rapid and Extraction-Free Detection of SARS-CoV-2 from Saliva by Colorimetric Reverse-Transcription Loop-Mediated Isothermal Amplification	162
Inflammation in Atherosclerosis—No Longer a Theory	160
Clinical Performance of Two SARS-CoV-2 Serologic Assays	160
Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease	132
Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation	129
Lipoprotein(a) and Cardiovascular Disease	107
Limits of Detection of 6 Approved RT–PCR Kits for the Novel SARS-Coronavirus-2 (SARS-CoV-2)	107
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays	106
Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity	97
Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies	96
Rapid Detection of SARS-CoV-2 by Low Volume Real-Time Single Tube Reverse Transcription Recombinase Polymerase Amplification Using an Exo Probe with an Internally Linked Quencher (Exo-IQ)	95
SARS-CoV-2 Serology: Much Hype, Little Data	83
Routine Laboratory Blood Tests Predict SARS-CoV-2 Infection Using Machine Learning	75
National Kidney Foundation Laboratory Engagement Working Group Recommendations for Implementing the CKD-EPI 2021 Race-Free Equations for Estimated Glomerular Filtration Rate: Practical Guidance for Cl	72
Investigational Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Event Prediction and Diagnosis	70
The Role of Metagenomics and Next-Generation Sequencing in Infectious Disease Diagnosis	66
Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test	63
Metagenomic Analysis Reveals Clinical SARS-CoV-2 Infection and Bacterial or Viral Superinfection and Colonization	62
Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease	59
Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC’s Analytical Variables Working Group	59
Clinical Performance of the Roche SARS-CoV-2 Serologic Assay	58
Clinical Evaluation of an Improved Metagenomic Next-Generation Sequencing Test for the Diagnosis of Bloodstream Infections	56

Clinical Impact of the Refit CKD-EPI 2021 Creatinine-Based eGFR Equation	51
Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2	51
Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaborati	50
Lateral Flow Assays in Infectious Disease Diagnosis	48
Antibody Profiles in Mild and Severe Cases of COVID-19	48
Personalized Reference Intervals in Laboratory Medicine: A New Model Based on Within-Subject Biological Variation	47
Cautionary Note on Contamination of Reagents Used for Molecular Detection of SARS-CoV-2	47
Myocardial Injury and the Release of Troponins I and T in the Blood of Patients	47
Efficiency Correction Is Required for Accurate Quantitative PCR Analysis and Reporting	44
The Dangers of Using Cq to Quantify Nucleic Acid in Biological Samples: A Lesson From COVID-19	41
A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test	41
Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis	41
Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a)	38
Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?	38
Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 Infection	37
Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer	36
SARS-CoV-2 Nucleocapsid Plasma Antigen for Diagnosis and Monitoring of COVID-19	36
Verification of Harmonization of Serum Total and Free Prostate-Specific Antigen (PSA) Measurements and Implications for Medical Decisions	33
Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer	33
Understanding Patient-Based Real-Time Quality Control Using Simulation Modeling	32
Noninvasive Fetal Genotyping by Droplet Digital PCR to Identify Maternally Inherited Monogenic Diabetes Variants	32
Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study	31
Analytical Considerations in Deriving 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin Assays: Educational Recommendations from the IFCC Committee on Clinical Application o	30
Sex Differences in Cardiac Troponin I and T and the Prediction of Cardiovascular Events in the General Population	29
SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission	29
Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues	29
Navigating Clinical Utilization of Direct-from-Specimen Metagenomic Pathogen Detection: Clinical Applications, Limitations, and Testing Recommendations	29
Forever Connected: The Lifelong Biological Consequences of Fetomaternal and Maternofetal Microchimerism	29
Obesity and Kidney Function: A Two-Sample Mendelian Randomization Study	29
Serum Prostate-Specific Antigen Testing for Early Detection of Prostate Cancer: Managing the Gap between Clinical and Laboratory Practice	29
Characteristics of Fetal Extrachromosomal Circular DNA in Maternal Plasma: Methylation Status and Clearance	28
Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance	28
Assessment of Multiplex Digital Droplet RT-PCR as a Diagnostic Tool for SARS-CoV-2 Detection in Nasopharyngeal Swabs and Saliva Samples	27
Performance of a Paired-End Sequencing-Based Noninvasive Prenatal Screening Test in the Detection of Genome-Wide Fetal Chromosomal Anomalies	27
Evolving Applications of Artificial Intelligence and Machine Learning in Infectious Diseases Testing	27
High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19	27
Multiple Myeloma Minimal Residual Disease Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone Marrow	27
Getting Cardiac Troponin Right: Appraisal of the 2020 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elev	27
Assessing the Accuracy and Clinical Utility of ChatGPT in Laboratory Medicine	26
Artificial Intelligence and Mapping a New Direction in Laboratory Medicine: A Review	26
Molecular and Serological Assays for SARS-CoV-2: Insights from Genome and Clinical Characteristics	26
Proficiency Testing to Assess Technical Performance for CTC-Processing and Detection Methods in CANCER-ID	25
Digital Microfluidic Hemagglutination Assays for Blood Typing, Donor Compatibility Testing, and Hematocrit Analysis	25
Triglycerides as a Shared Risk Factor between Dementia and Atherosclerotic Cardiovascular Disease: A Study of 125 727 Individuals	25
99th Percentile Upper-Reference Limit of Cardiac Troponin and the Diagnosis of Acute Myocardial Infarction	25
Targeted-Sequencing Workflows for Comprehensive Drug Resistance Profiling of Mycobacterium tuberculosis Cultures Using Two Commercial Sequencing Platforms: Comparison of Analytical and Diagnostic Perf	24
Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer Patients	24
Genomic Prediction of Antimicrobial Resistance: Ready or Not, Here It Comes!	24
Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study	24
Implementation of High-Sensitivity and Point-of-Care Cardiac Troponin Assays into Practice: Some Different Thoughts	24

Time-Dependent Apparent Increase in dd-cfDNA Percentage in Clinically Stable Patients Between One and Five Years Following Kidney Transplantation	24
Comprehensive Analysis of Congenital Adrenal Hyperplasia Using Long-Read Sequencing	23
Preparedness and Rapid Implementation of External Quality Assessment Helped Quickly Increase COVID-19 Testing Capacity in the Republic of Korea	23
Ultra-Early Differential Diagnosis of Acute Cerebral Ischemia and Hemorrhagic Stroke by Measuring the Prehospital Release Rate of GFAP	23
The Truth about SARS-CoV-2 Cycle Threshold Values Is Rarely Pure and Never Simple	23
Jagged Ends of Urinary Cell-Free DNA: Characterization and Feasibility Assessment in Bladder Cancer Detection	23
Standardized Workflow for Precise Mid- and High-Throughput Proteomics of Blood Biofluids	23
Clinical Application of Multiple Reaction Monitoring-Mass Spectrometry to Human Epidermal Growth Factor Receptor 2 Measurements as a Potential Diagnostic Tool for Breast Cancer Therapy	23
A Highly Automated Mobile Laboratory for On-site Molecular Diagnostics in the COVID-19 Pandemic	22
Analytical Sensitivity and Specificity of Four Point of Care Rapid Antigen Diagnostic Tests for SARS-CoV-2 Using Real-Time Quantitative PCR, Quantitative Droplet Digital PCR, and a Mass Spectrometric	22
Biological Variation of Cardiac Troponins in Health and Disease: A Systematic Review and Meta-analysis	21
Cell-Free DNA as Biomarker for Sepsis by Integration of Microbial and Host Information	21
SwabExpress: An End-to-End Protocol for Extraction-Free COVID-19 Testing	21
Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study	21
Nanopore Identification of Single Nucleotide Mutations in Circulating Tumor DNA by Multiplexed Ligation	21
Growth Differentiation Factor (GDF)-15 and Cardiometabolic Outcomes among Older Adults: The Atherosclerosis Risk in Communities Study	20
AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 Emergency Use Authorization and Laboratory-Developed Test Serologic Testing in Clinical Laboratories	20
Type 2 Myocardial Infarction: Evolving Approaches to Diagnosis and Risk-Stratification	20
Cardiac Troponin Testing in Patients with COVID-19: A Strategy for Testing and Reporting Results	20
Development of a Plasma Biomarker Diagnostic Model Incorporating Ultrasensitive Digital Immunoassay as a Screening Strategy for Alzheimer Disease in a Chinese Population	19
The Vitamin D Metabolite Ratio Is Independent of Vitamin D Binding Protein Concentration	19
RIbench: A Proposed Benchmark for the Standardized Evaluation of Indirect Methods for Reference Interval Estimation	19
Genome-Scale Methylation Analysis of Circulating Cell-Free DNA in Gastric Cancer Patients	19
How Can We Ensure Reproducibility and Clinical Translation of Machine Learning Applications in Laboratory Medicine?	19
Distinguishing Non-Small Cell Lung Cancer Subtypes in Fine Needle Aspiration Biopsies by Desorption Electrospray Ionization Mass Spectrometry Imaging	19
Cell-Free DNA Fragmentomics: The New “Omics” on the Block	18
Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome	18
Plasma Glial Fibrillary Acidic Protein in the Alzheimer Disease Continuum: Relationship to Other Biomarkers, Differential Diagnosis, and Prediction of Clinical Progression	18
Circulating Tumor DNA as a Biomarker for Monitoring Patients with Solid Cancers: Comparison with Standard Protein Biomarkers	18
Identifying Optimal Loci for the Molecular Diagnosis of Microsatellite Instability	18
Diagnostic Performance of Metagenomic Next-Generation Sequencing in Pediatric Patients: A Retrospective Study in a Large Children’s Medical Center	18
Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine	18
Single-Cell Identification, Drug Susceptibility Test, and Whole-genome Sequencing of Helicobacter pylori Directly from Gastric Biopsy by Clinical Antimicrobial Susceptibility Test Ramanometry	18
Whole-Transcriptome Analysis by RNA Sequencing for Genetic Diagnosis of Mendelian Skin Disorders in the Context of Consanguinity	17
Optimizing the Use of High-Sensitivity Troponin Assays for the Early Rule-out of Myocardial Infarction in Patients Presenting with Chest Pain: A Systematic Review	17
Chemical Characterization and Quantification of Circulating Intact PTH and PTH Fragments by High-Resolution Mass Spectrometry in Chronic Renal Failure	17
Metabolomics in Clinical Practice: Improving Diagnosis and Informing Management	17
Circular RNA Sequencing Reveals Serum Exosome Circular RNA Panel for High-Grade Astrocytoma Diagnosis	17
Evaluation of Orthogonal Testing Algorithm for Detection of SARS-CoV-2 IgG Antibodies	17
Development of Label-Free Immunoassays as Novel Solutions for the Measurement of Monoclonal Antibody Drugs and Antidrug Antibodies	17
Glycated Albumin for the Diagnosis of Diabetes in US Adults	17
Regression-Adjusted Real-Time Quality Control	17
The Effect of Preanalytical and Physiological Variables on Cell-Free DNA Fragmentation	16
Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in Plasma	16
Choice of Statistical Tools for Outlier Removal Causes Substantial Changes in Analyte Reference Intervals in Healthy Populations	16
Very Low-Density Lipoprotein Cholesterol May Mediate a Substantial Component of the Effect of Obesity on Myocardial Infarction Risk: The Copenhagen General Population Study	16
Achieving Expert-Level Interpretation of Serum Protein Electrophoresis through Deep Learning Driven by Human Reasoning	15
High-Throughput CRISPR–Cas13 SARS-CoV-2 Test	15
Overinterpretation of Research Findings: Evaluation of “Spin” in Systematic Reviews of Diagnostic Accuracy Studies in High–Impact Factor Journals	15
Biomarkers for Risk Assessment in Atrial Fibrillation	15
Giant Magnetoresistive Nanosensor Analysis of Circulating Tumor DNA Epidermal Growth Factor Receptor Mutations for Diagnosis and Therapy Response Monitoring	15
Optimizing Available Tools for Achieving Result Standardization: Value Added by Joint Committee on Traceability in Laboratory Medicine (JCTLM)	15
Development and Analytical Validation of a Reverse Transcription Droplet Digital PCR (RT-ddPCR) Assay forPD-L1Transcripts in Circulating Tumor Cells	15
Current State of Laboratory Automation in Clinical Microbiology Laboratory	15
Glycated Albumin and Risk of Mortality in the US Adult Population	14
Interoperability: COVID-19 as an Impetus for Change	14
Recent Advances in Rapid Antimicrobial Susceptibility Testing	14
Biomarkers and Clinical Laboratory Detection of Acute and Chronic Ethanol Use	14
Urinary Metabolite Biomarkers for the Detection of Synthetic Cannabinoid ADB-BUTINACA Abuse	14
Evaluation of Sperm DNA Integrity by Mean Number of Sperm DNA Breaks Rather Than Sperm DNA Fragmentation Index	14
The European Biological Variation Study (EuBIVAS): Biological Variation Data for Coagulation Markers Estimated by a Bayesian Model	14
A Collaborative Effort to Define Classification Criteria forATMVariants in Hereditary Cancer Patients	14
Mass Spectrometry for COVID-19	14
Sample Multiplexing: Increased Throughput for Quantification of Total Testosterone in Serum by Liquid Chromatography-Tandem Mass Spectrometry	14
HDL in Morbidity and Mortality: A 40+ Year Perspective	14
Validation of an LC-MS/MS Method Using Solid-Phase Extraction for the Quantification of 1-84 Parathyroid Hormone: Toward a Candidate Reference Measurement Procedure	14
ApoB vs non-HDL-C vs LDL-C as Markers of Cardiovascular Disease	14
Development of an LC-MRM-MS-Based Candidate Reference Measurement Procedure for Standardization of Serum Apolipoprotein (a) Tests	13
Cardiac Biomarkers in Pediatrics: An Undervalued Resource	13
Breath Metabolites to Diagnose Infection	13
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure	13
Long-Term Longitudinal Stability of Kidney Filtration Marker Measurements: Implications for Epidemiological Studies and Clinical Care	13
What Is Extrachromosomal Circular DNA and What Does It Do?	13
Variability of “Reported Fetal Fraction” in Noninvasive Prenatal Screening (NIPS)	13
Early Rule-Out Strategies in the Emergency Department Utilizing High-Sensitivity Cardiac Troponin Assays	13
Empiricism in Microsampling: Utilizing a Novel Lateral Flow Device and Intrinsic Normalization to Provide Accurate and Precise Clinical Analysis from a Finger Stick	13
Utility of Circulating Free DNA Fragmentomics in the Prediction of Pathological Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer	13
Elementary Overview of Heavy Metals	13
Harmonization Status of Serum Ferritin Measurements and Implications for Use as Marker of Iron-Related Disorders	13
Laboratory-Developed Tests in the New European Union 2017/746 Regulation: Opportunities and Risks	12

Data Mining Approaches to Reference Interval Studies	12
Urinary Cell-Free DNA in Liquid Biopsy and Cancer Management	12
Prognostic Value of Programmed Cell Death-Ligand 1 Expression in Tumor-Infiltrating Lymphocytes and Viral Load in Peripheral Blood Mononuclear Cells for Epstein–Barr Virus–Positive Nasopharyngeal Carc	12
Multiplex PCR and Nanopore Sequencing of Genes Associated with Antimicrobial Resistance in Neisseria gonorrhoeae Directly from Clinical Samples	12
A Comprehensive Molecular Analysis of in Vivo Isolated EpCAM-Positive Circulating Tumor Cells in Breast Cancer	12
Interpreting EQA—Understanding Why Commutability of Materials Matters	12
Guidance on Which Calibrators in a Metrologically Traceable Calibration Hierarchy Must Be Commutable with Clinical Samples	12
Evaluation of Neutralizing Antibodies against SARS-CoV-2 Variants after Infection and Vaccination Using a Multiplexed Surrogate Virus Neutralization Test	12
Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12 139 Cancer Patients	12
An Update on Laboratory-Based Diagnostic Biomarkers for Multiple Sclerosis and Beyond	12
Clinical Translation and Evaluation of a Handheld and Biocompatible Mass Spectrometry Probe for Surgical Use	12
Comprehensive Analysis of Fragile X Syndrome: Full Characterization of the FMR1 Locus by Long-Read Sequencing	12
Enhanced Performance of DNA Methylation Markers by Simultaneous Measurement of Sense and Antisense DNA Strands after Cytosine Conversion	12
Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial	11
Relative Efficacy of Different Strategies for Inhibition of in Vitro Glycolysis	11
Plasma Ionized Calcium and Risk of Cardiovascular Disease: 106 774 Individuals from the Copenhagen General Population Study	11
Breast Cancer Detection and Treatment Monitoring Using a Noninvasive Prenatal Testing Platform: Utility in Pregnant and Nonpregnant Populations	11
TOP-Plus Is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability	11
A Translational Tool to Facilitate Use of Apolipoprotein B for Clinical Decision-Making	11
Toward Clinical Application of Leukocyte Counts Based on Targeted DNA Methylation Analysis	11
Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple Myeloma	11
Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational Burden	11
Comparison of Proteomic Measurements Across Platforms in the Atherosclerosis Risk in Communities (ARIC) Study	11
Type I Interferon in Children with Viral or Bacterial Infections	11
Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma	11
Diagnostic Stewardship in Clinical Microbiology, Essential Partner to Antimicrobial Stewardship	11
Uncertainty in Estimated Glomerular Filtration Rate Is Much Larger than the Race Adjustment Term	11
Sex-Specific Kinetics of High-Sensitivity Cardiac Troponin I and T following Symptom Onset and Early Presentation in Non-ST-Segment Elevation Myocardial Infarction	11
Prognostic Value of Low-Pass Whole Genome Sequencing of Circulating Tumor DNA in Metastatic Castration-Resistant Prostate Cancer	11
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform	11
Diagnostic Validation of a High-Sensitivity Cardiac Troponin I Assay	11
Digital Quantification of Chemical Oligonucleotide Synthesis Errors	10
Dutch National Round Robin Trial on Plasma-Derived Circulating Cell-Free DNA Extraction Methods Routinely Used in Clinical Pathology for Molecular Tumor Profiling	10
Neutral-Coating Capillary Electrophoresis Coupled with High-Resolution Mass Spectrometry for Top-Down Identification of Hemoglobin Variants	10
Clinical Decision Support for Laboratory Testing	10
Error Characterization and Statistical Modeling Improves Circulating Tumor DNA Detection by Droplet Digital PCR	10
Prognostic Metrics Associated with Inflammation and Atherosclerosis Signaling Evaluate the Burden of Adverse Clinical Outcomes in Ischemic Stroke Patients	10
How Well Do Laboratories Adhere to Recommended Guidelines for Cardiac Biomarkers Management in Europe? The CArdiac MARker Guideline Uptake in Europe (CAMARGUE) Study of the European Federation of Labo	10
Identifying Clinically Relevant Bacteria Directly from Culture and Clinical Samples with a Handheld Mass Spectrometry Probe	10
Machine Learning in Laboratory Medicine: Recommendations of the IFCC Working Group	10
Deep Convolutional Neural Networks Implementation for the Analysis of Urine Culture	10
Ultrasensitive DNA Immune Repertoire Sequencing Using Unique Molecular Identifiers	10
A Machine Learning Approach for the Automated Interpretation of Plasma Amino Acid Profiles	10
Direct Water-Assisted Laser Desorption/Ionization Mass Spectrometry Lipidomic Analysis and Classification of Formalin-Fixed Paraffin-Embedded Sarcoma Tissues without Dewaxing	10
Metabolomic Fingerprints in Large Population Cohorts: Impact of Preanalytical Heterogeneity	10
Limited Evidence for Use of a Black Race Modifier in eGFR Calculations: A Systematic Review	10
Patient-Based Real Time QC	10
Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective Study	10
Plasma Concentrations of Magnesium and Risk of Dementia: A General Population Study of 102 648 Individuals	9
LIPCAR Is Increased in Chronic Symptomatic HF Patients. A Sub-Study of the GISSI-HF Trial	9
Erratum: The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020	9
Ceramides and Phosphatidylcholines Associate with Cardiovascular Diseases in the Elderly	9
Next-Generation Sequencing–Based Analysis of Urine Cell-Free mtDNA Reveals Aberrant Fragmentation and Mutation Profile in Cancer Patients	9
Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection	9
Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of Concern	9
Microbial Taxonomy: How and Why Name Changes Occur and Their Significance for (Clinical) Microbiology	9
Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results	9
Effect of Macrotroponin in a Cohort of Community Patients with Elevated Cardiac Troponin	9
Optimized Droplet Digital PCR Assay on Cell-Free DNA Samples for Non-Invasive Prenatal Diagnosis: Application to Beta-Thalassemia	9
Single Cell and Plasma RNA Sequencing for RNA Liquid Biopsy for Hepatocellular Carcinoma	9
Evaluating the Clinical Utility of a Long-Read Sequencing-Based Approach in Prenatal Diagnosis of Thalassemia	9
Role of Cardiac Biomarkers in Epidemiology and Risk Outcomes	9
Use of Racial and Ethnic Categories in Medical Testing and Diagnosis: Primum Non Nocere	9
The Present and Future of Lipid Testing in Cardiovascular Risk Assessment	9
Measurement of Immature Reticulocytes in Dried Blood Spots by Mass Spectrometry	9
Commutability Assessment of Candidate Reference Materials for Lipoprotein(a) by Comparison of a MS-based Candidate Reference Measurement Procedure with Immunoassays	9
Improving Harmonization and Standardization of Expanded Newborn Screening Results by Optimization of the Legacy Flow Injection Analysis Tandem Mass Spectrometry Methods and Application of a Standardiz	9
Average of Patient Deltas: Patient-Based Quality Control Utilizing the Mean Within-Patient Analyte Variation	9
High Speed Centrifugation Before Frozen Storage of Plasma Is Critical for Quantitative Analysis of Mitochondrial-Derived Cell-Free DNA	9
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus	9
Applications of Digital Microscopy and Densely Connected Convolutional Neural Networks for Automated Quantification of Babesia-Infected Erythrocytes	8
Sex Hormone-Binding Globulin and Risk of Coronary Heart Disease in Men and Women	8
Challenges in Translating Clinical Metabolomics Data Sets from the Bench to the Bedside	8
Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Tracking	8
New Sampson Low-Density Lipoprotein Equation: Better Than Friedewald and Martin-Hopkins	8
At-Home Testing for Infectious Diseases: The Laboratory Where You Live	8
Expert-Level Immunofixation Electrophoresis Image Recognition based on Explainable and Generalizable Deep Learning	8
Plasma Clearance of B-Type Natriuretic Peptide (BNP) before and after Bariatric Surgery for Morbid Obesity	8
Angiogenic Biomarkers for Risk Stratification in Women with Preeclampsia	8
CRISPR Cas9-Mediated Selective Isothermal Amplification for Sensitive Detection of Rare Mutant Alleles	8
Evaluation of Three Commercial Automated Assays for the Detection of Anti-SARS-CoV-2 Antibodies	8
Liquid Biopsy and Immuno-Oncology for Advanced Nonsmall Cell Lung Cancer	8
Causal Relationship between Plasma Adiponectin and Body Mass Index: One- and Two-Sample Bidirectional Mendelian Randomization Analyses in 460 397 Individuals	8
High-Sensitivity Single Molecule Array Assays for Pathological Isoforms in Parkinson’s Disease	8
Recognition of the Prehospital Preanalytical Phase: Collaborative Efforts between Laboratory Medicine and Emergency Medicine to Ensure Quality Testing	8
Combining First and Second-Tier Newborn Screening in a Single Assay Using High-Throughput Chip-Based Capillary Electrophoresis Coupled to High-Resolution Mass Spectrometry	8
Perspective on New Equations for Estimating Glomerular Filtration Rate	8
Cardiovascular Disease in Women: Understanding the Journey	8
Lot-to-Lot Variation for Commercial High-Sensitivity Cardiac Troponin: Can We Realistically Report Down to the Assay’s Limit of Detection?	7
Liquid Biopsy Hotspot Variant Assays: Analytical Validation for Application in Residual Disease Detection and Treatment Monitoring	7
Galaxy Is a Suitable Bioinformatics Platform for the Molecular Diagnosis of Human Genetic Disorders Using High-Throughput Sequencing Data Analysis: Five Years of Experience in a Clinical Laboratory	7
Circulating Cell-Free Mitochondrial DNA in Cerebrospinal Fluid as a Biomarker for Mitochondrial Diseases	7
Sex-Specific 99th Percentile URLs for Cardiac Troponin Assays—Their Time Has Come	7
A Three-Site Immunoassay for High-Sensitivity Cardiac Troponin I with Low Immunoreactivity for Macrocomplexes	7
The Inflammation Biomarker GlycA Reflects Plasma N-Glycan Branching	7